Sisram MedicalSRAMF 60 FCF Margin % is 6.87% as of Dec. 2025, which is 31% below its 10-year median of 9.92. GuruFocus rates SRAMF with a GF Score™ of 60/100 and a GF Value™ of $0.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Sisram Medical ranks better than 54.97% on this metric.
The historical rank and industry rank for Sisram Medical's FCF Margin % or its related term are showing as below:
SRAMF'
s FCF Margin % Range Over the Past 10 Years
Min: -11.93 Med: 9.92 Max: 12.67
Current: 1.87
During the past 12 years, the highest FCF Margin % of Sisram Medical was 12.67%. The lowest was -11.93%. And the median was 9.92%.
SRAMF's FCF Margin % is ranked better than 54.97% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs SRAMF: 1.87
Sisram Medical FCF Margin % Related Terms
Sisram Medical FCF Margin % Historical Data
* Premium members only.
The historical data trend for Sisram Medical's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sisram Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sisram Medical FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Sisram Medical's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sisram Medical (SRAMF) has a FCF Margin % of 6.87% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sisram Medical and its competitors. This is 31% below median its historical median of 9.92. According to the industry distribution chart, Sisram Medical ranks #367 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 45%.
Is Sisram Medical's FCF Margin % too high?
Sisram Medical's current FCF Margin % of 6.87% is 31% below median its 10-year median of 9.92. Based on the distribution chart, Sisram Medical ranks #367 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sisram Medical has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sisram Medical ranks #367 out of 815 companies for FCF Margin %. This puts Sisram Medical in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sisram Medical and its competitors. Sisram Medical's current FCF Margin % is 6.87%, which is 31% below median its own 10-year median of 9.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.95, compared to a current price of $0.44 — trading 53.9% below its estimated fair value. The current FCF Margin % is 6.87%, which is 31% below median its 10-year median of 9.92. Sisram Medical's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current FCF Margin % is 6.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sisram Medical (SRAMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued.
The current stock price of $0.44 is trading 53.9% below its estimated GF Value™ of $0.95.
GuruFocus considers Sisram Medical to be Significantly Undervalued.
Key valuation signals for SRAMF:
FCF Margin %: 6.87% (31% below median its 10-year median of 9.92)
GF Value™: $0.95 vs. price of $0.44 (53.9% below fair value)
No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
60GF Score
Get the complete analysis for SRAMF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRAMF has been successfully added to your 
